You are using an older browser version. Please use a supported version for the best MSN experience.

To outperform market, JPMorgan China fund picks tech hardware, EV suppliers and health care stocks in correction

South China Morning Post logo South China Morning Post 09/06/2021
a person riding a motorcycle on a city street: A giant monitor shows stock market data in Shanghai. Chinese stocks have been stuck in a rangebound pattern in the past few months. Photo: EPA-EFE A giant monitor shows stock market data in Shanghai. Chinese stocks have been stuck in a rangebound pattern in the past few months. Photo: EPA-EFE

China's stock market correction has given JPMorgan Asset Management a chance to buy their favourites on the cheap. To beat the market, its money managers are going for technology hardware, pharmaceutical leaders and electric-vehicle (EV) suppliers.

The firm's US$7.9 billion A-Share Opportunities Fund returned 71.1 per cent in 2020 to beat the 27 per cent advance in the broader CSI 300 Index, and ranked among the bank's top performers in the Asia-Pacific region. This year, however, it has struggled with a 1.3 per cent gain as the rally faded and prices locked in rangebound trading patterns over the past three months.

The fund's current "high conviction" bets are driven by bottom-up analysis, which favours cyclical growth areas such as technology hardware, pharmaceutical outsourcing and EV supply chain, co-manager Rebecca Jiang said in an interview.

Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team.

"We look to periods of weakness as good buying opportunities in favoured stocks," said Hong Kong-based Jiang. "When valuations of growth and value stocks converge, the better long-term opportunity will be found in structural growth stocks, which offer the chance of compounding returns."

The fund had 21.1 per cent of its money in information technology sector, 18.1 per cent in consumer staples, 17.3 per cent in financials and 13.4 per cent in health care among its largest allocations at the end of April 30. Its top 10 portfolio holdings include Ping An Insurance, Wuliangye Yibin, BOE Technology and Contemporary Amperex.

After a bright start to the year, Chinese stocks have lost their mojo and regressed into rangebound trading patterns for most of the past three months. Jiang attributed that inertia to fading euphoria from China's first-quarter economic rebound and efforts to normalise accommodative monetary policies.

a person wearing a suit and tie: Rebecca Jiang, fund manager at JPMorgan Asset Management in Hong Kong. Photo: Handout © Provided by South China Morning Post Rebecca Jiang, fund manager at JPMorgan Asset Management in Hong Kong. Photo: Handout

While recent yuan appreciation has drawn foreign investors back into onshore stocks, efforts to curb its rally will have negative consequences for the market, according to BCA Research. The recent fund inflows, however, are unsustainable on a cyclical basis.

"While policy tightening has brought multiples closer to earth than last year, the upside in Chinese stock prices will be capped by subsiding stimulus and slower profit growth ahead," strategist Jing Sima said in a June 9 report. "As such, a decisive breakout to the upside in Chinese stock prices will require major reflationary catalysts, and it is the reason we are still risk averse on Chinese equities."

Even so, the A-Share Opportunities Fund has taken a long view of the economic outlook and increased its holdings in some of the prominent bets in the market, according to fund reports. It raised its net-asset weights in EV battery producer Contemporary Amperex, Ping An Insurance and Jiangsu Hengrui Medicine, for example, over the past four months, according to the reports.

"The hardware sector is in a sweet spot at the moment," Jiang said in the interview. "From a cyclical perspective, hardware is well supported by the global economic recovery as the sector is more sensitive to the macroeconomic cycle than software," she added. "From a structural perspective, it is a beneficiary of the US-China decoupling as China focuses on developing import substitution."

Replay Video

Another structural change is the increased demand for health care services and products, Jiang added, including health care infrastructure, preventive treatment and vaccine development. Pharmaceutical research and development, R&D outsourcing, and medical-equipment manufacturing are "attractive."

Even in high-profile industries like EV manufacturing in which China is the biggest market globally, Jiang said it's possible to ride the trend by taking a deeper dive, while steering clear of expensive carmakers that attract government scrutiny and other industry risks.

"When it comes to electric vehicles, we prefer to get under the bonnet," Jiang said. "We do this by looking up and down the EV supply chain for areas with the most attractive pricing power."

She prefers battery companies which supply to many different carmakers, including companies which compete with one another. That way "it doesn't matter to our portfolios which EV brand does best at any point in time. The supplier will benefit either way."

Additional reporting by David Yong

More Articles from SCMP

China gets tough on financial sector risk management, extends contingency planning to more institutions

How US belligerence is driving China and Russia closer together

Inside the luxury mansions of The Real Housewives of Beverly Hills: from Kyle Richards’ seven-bed house to Erika Jayne’s ‘modest’ new pad, which cast member has the most expensive home?

Who’s the richest Olsen sister? Full House twins Mary-Kate and Ashley share a combined US$500 million fortune – but don’t forget little sister, Marvel star Elizabeth

China-Australia relations: how an underperforming Australian dollar could entice new trade partners

This article originally appeared on the South China Morning Post (www.scmp.com), the leading news media reporting on China and Asia.

Copyright (c) 2021. South China Morning Post Publishers Ltd. All rights reserved.

AdChoices
AdChoices
AdChoices

More from South China Morning Post

South China Morning Post
South China Morning Post
image beaconimage beaconimage beacon